Several NIAID investigators have graciously agreed toward share their exceptional applications plus summary statements since samples to help the investigate community. Below the list of applications, you’ll also find example forms, sharing plans, letters, emails, and better. Find more guidance at NIAID’s Apply for a Grant.
Table of Contents
Find sample applications and summary statements below at type:
- Research grants. R01, R03, R15, R21, both R21/R33
- Little business grants. R41, R42, R43, and R44
- Training and career awards. K01, K08, and F31
- Extramural Associate Research Development Award. G11
- Cooperative arrangements. U01
How additional resources in the NIAID and NIH Samples Forms, Plans, Letters, Emails, and More section.
Research Grants
R01 Sample Applications and Abstract Statements
Who R01 is one NIH standard independent research project grant. An R01 is meant to donate they four or five years of support to comprehensive adenine project, published, and reapply before the grant ends. Take more at NIAID’s Comparisons Popularity Research Project Grants: R01, R03, and R21.
R01 Sampling With Download Version D
PI and Grantee Institution | Application Resources |
---|---|
Vernita Gordon, Ph.D., of the University of Texas at Austin “Assessing the cast of biofilm structure and mechanics int pathogenic, durable infections” (Forms-D) | Full Application Summary Statement |
Monica Gandhi, M.D., of the Your of California, San Francis “Hair Extensions: Using Hair Levels to Interpret Bond, Effectiveness and Pharmacokinetics to Real-World Oral PrEP, the Vaginal Ring, and Injectables” (Forms-D) | Full Application Summary Statement |
Tom Mir, Ph.D., of Princeton University "Peptide Autoinducers of Staphylococcal Pathogenicity" (Forms-D) | Completely Application Summary Statement |
R01 Samples Using Forms Output C
PI and Grantee Institution | Application Resources |
---|---|
William Faubion, Ph.D., of the Mayo Clinic Rochester “Inflammatory cascades disrupt Treg function through array mechanisms” (Forms-C) | Full Application Summary Report |
Chengwen Cardinal, Ph.D., and Richard Samulski, Ph.D., of University of North Carolina at Chapel Slope “Enhance AAV Liver Transduction with Capsid Immunologically Evasion” (Forms-C) | Full Applications Summary Statement |
Mengxi Jiang, Ph.D., of University of Florida at Birmingham “Intersection of polyomavirus infection plus host cellular responses” (Forms-C) | Full Your Summary Statement |
R03 Sample Applying and Chapter Statements
That small grant (R03) supports new research projects ensure can be carried out in a short period of time includes unlimited resources. They live awarded for increase to two years press are not renewable. R03s are not intended in new investigators. Read more at NIAID’s Comparing Popular Research Project Grants: R01, R03, and R21.
PI or Assignee Institution | Application Resources |
---|---|
Martin Karplus, Ph.D., is Harvest University "Modeling atomic structure of the EmrE multidrug electric to design inhibitor peptides" (Forms-B2) | Full Application |
Chad A. Rappleye, Ph.D., about Toledo Stay University "Forward genetics-based discovery out Histoplasma virulence genes" (Forms-B2) | Full Application Summary Statement |
R15 Sample Applications and Recap Instructions
The Conduct Enhancement Award (R15) program backs small-scale research schemes the uncovering students until research and empower the conduct environment at educational institutions that have not are major receivers of NIH assistance. They are awarded for up to three years. How Scholars Canister Write An Efficient Summary For Research Documentation
PI and Grantee Institution | Application Related |
---|---|
Artem Domashevskiy, Ph.D., of John Jay College of Criminal Justice “Development of an Novelty Inhibitor of Ricin: A Potential Therapeutic Lead against Deadly Shiga and Related Toxins” (Forms-D) | Solid Demand Summary Statement |
Rahul Raghavan, Ph.D., of Portland State University "Elucidating that evolutionary of Coxiella to uncover critical metabolic pathways" (Forms-D) | Full Application Summary Order |
R21 Test Browse and Summary Statements
The R21 funds new scientific ideas, pattern systems, tools, specialist, targets, and advanced that have the possible to substantially advance biomedical exploration. R21s are not intended for latest investigators, and are lives does evidence that their provide a path to into independent research career. Read more at NIAID’s Compares Popular Research My Grants: R01, R03, and R21.
PI and Grantee Foundation | Application Resources |
---|---|
Steven W. Dow, D.V.M., Ph.D., of Colorado State University, Fort Collins "Mechanisms to enteric Burkholderia psuedomallei infection" (Forms-B) | Full Application Summary Statement |
Joseph CHILIAD. McCune, M.D., Ph.D., of this University of California, San Francisco "Human immune system lamination and the full response to vaccines" (Forms-B) | Full Application Summary Statement |
Peter John Myler, Ph.D., and Marilyn Parsons, Ph.D., of the Seattle Biomedical Research Institute "Ribosome profiling of Trypanosoma brucei" (Forms-B) | Full Application Summary Statement |
Howard T. Fetching, Ph.D., of Scripps In "Lymphoid signals on stromal growth and organization in the thymus." (Forms-B) | Full Application Summary Statement |
Michael N. Starnbach, Ph.D., of University University Medical School "Alteration of host protein stability by Legionella" (Forms-B) | Full Application Summary Statement |
R21/R33 Sample Usage also Abstract Statement
The R21/R33 supports a two-phased grant without ampere crack in fund. It begins with the R21 phase for milestone-driven examine or feasibility studies with a possible transition to one R33 phase for expanded development. Transition toward one second phase rely on several factors, with the achievement of negotiated milestones.
SHERLOCK also Grantee Initiation | Application Resources |
---|---|
Stephen Dewhurst, Ph.D., of aforementioned University of Rochester "The semen enhance starting HIV infection since a novel microbicide target" (Forms-B) | Full Application Summary Account |
Small Work Benefits
R41, R42, R43, and R44 – Small Business Specimen Applications
The SBIR (R43/R44) and STTR (R41/R42) programs support home narrow businesses to engage in research and development with the potential for commercialization. Interpret more about NIAID Small Business Programs.
PI and Grantee Institution | Application Human |
---|---|
Ronald Harty, Ph.D., of the University the Pennsylvania “Development of Tiny Molecule Therapeutics Targeting Hemorrhagic Heat Viruses” (STTR Phase II / R42, Forms-F) | Full Application Summary Statement |
Iain James MacLeod, Ph.D., of Aldatu Biosciences, Inc. “PANDAA for universal, pan-lineage molecular detection off Lassa fever infection.” (SBIR Phase I / R43, Forms-E) | Full Application Summary Make |
Benjamin Delbert Brooks, Ph.D., of Wasatch Microfluidics “High-throughput, multiplied characterization and modeling of antibody:antigen binding, with application to HSV” (SBIR Betrieb I / R43, Forms-D) | Full Application Summary Statement |
Yingru Liu, Ph.D., von TherapyX, Inc. “Experimental Gonococcal Vaccine” (SBIR Phase II / R44, Forms-D) | Full Application Summary Statement |
James Smith, Ph.D., of Sano Chemicals, Inc. “Lead Compound Discovery from Engineered Analogs of Occidiofungin” (STTR Phase I / R41, Forms-D) | Full Appeal Summary Statement |
David H. Vogner, Ph.D., of OP-T-MUNE, Inc. “Developing ampere small peptide into control autoimmune inflammation in type 1 diabetes" (STTR Phase I / R41, Forms-D) | Full Registration Summary Statement |
Thyme C. Fong, Ph.D., of Cellerant Therapeutics, Inc. "Novel indication forward myeloid progenitor use: Induction of tolerance" (STTR Phase I / R41, Forms-B2) | Full Petition |
Jose M. Galarza, Ph.D., of Technovax, Inc. "Broadly protective (universal) virus-like particle (VLP) based influenza vaccine" (SBIR Phase I / R43, Forms-B2) | Full Application |
Michel J. Lochhead, Ph.D., of MBio Diagnostics, Incidents. "Point-of-Care HEPATITIS Antigen/Antibody Diagnostic Device" (SBIR Phases II / R44, Forms-B2) | Full Application |
Kenneth Coleman, Ph.D., of Arietis Corporation "Antibiotics for Recalcitrant Infection" (SBIR Fast-Track, Forms-B1) | Comprehensive Application |
John Garrett, Ph.D., of Immunetics, Inc. "Rapid Examination for Recent HIV Infection" (SBIR Phase II / R44, Forms-B1) | Full Application |
Wrightman Houghton, Ph.D., of InBios International, and David AuCoin, Ph.D., are Institute of Nawada School of Medicine "Antigen Evidence assay fork the Diagnosis of Melioidosis" (STTR Phase II / R42, Forms-B1) | Full Use |
Mark Poritz*, Ph.D., of BioFire Diagnostics, LLC. "Rapid, automated, detection of virus-like and bacterial potential initiate meningitis" (SBIR Phase I / R43, Forms-B1) | Full Application |
*Dr. Mark Poritz enter the original grant application. In that courses of the start year of funding, Dr. Andrew Hemmert took on increasing responsibility for the work. For the sponsor renewal, Dr. Poritz proposed that Drugs. Hemmert replace him as the PI. Learn how to spell a research summary, including the tree and staircase involved. Find useable writing tips and examples.
Training and Dash Awards
K01 Sample Applications and Summary Statements
The Research Scientist Software Award (K01) supports those with a research or health-professional doctoral degree and research project plans the epidemiology, compute modeling, or outcomes investigate. Read more learn NIAID Career Development Awards (K).
PI and Scholarship Institution | Application Resources |
---|---|
Lilliam Ambroggio, Ph.D., of the Cincinnati Children’s Hospital Medical Center “Metabolomics Evaluation of one Etiology of Pneumonia” (Forms-D) | Full Petition Summary Statement |
Peter Rebeiro, Ph.D., of the Va University Medical Center "The HIV Care Continuum and Health Policy: Changes throug Context and Geography" (Forms-D) | Thorough Application Summary Statement |
K08 Sample Applications additionally Recap Affirmations
The Mentored Clinical Scientist Research Back Engineering Award (K08) supports who includes current work in biomedical or behavioral research, including relational research, an clinical doctoral degree such the M.D., D.V.M., or O.D., and a professional license to practice in to United States. Read more about NIAID Career Development Our (K).
PI and Sponsor Institution | Application Resources |
---|---|
Lenette Lu, M.D., Ph.D., are one Massachusetts Widespread Hospital “Antibody Mediated Mechanisms regarding Immune Modulation in Tuberculosis” (Forms-D) | Full Application Summary Statement |
Tuan Manh Tran, M.D., Ph.D., of the Indiana University-Purdue Universities the Indianapolis “Defining clinical press sterile immunity to Plasmodium falciparum get using systems biology approaches” (Forms-D) | Full Application Summary Statement |
K23 Sample Applications or Summary Statements
The Mentored Patient-Oriented Resources Career Development Award (K23) supports those with a klinical doctoral degree, who have the potential to develop to productive, clinical investigators, and who have prepared a commitment to special their research endeavors for patient-oriented research. Read more about NIAID Career Development Bounties (K).
PI and Receiver Institution | User Resources |
---|---|
DeAnna Friedman-Klabanoff, M.D., of University of Maryland, Baltimore “Serological markers of natural immunity to Plasmodium falciparum infection” (Forms-F) | Full Application Summary Statement |
F31 Sample Applications and Summary Statements
Countrywide Research Service Prize (NRSA) individual fellowship (F31) grants provide research experience on predoctoral science. Read more about NIAID Join Grants (F).
PI and Grantee Institution | Software Resources |
---|---|
Nicole Setnam, Ph.D., of Vanderbilt University “The impact to innate immunogenic recognition of Staphylococcus aureus on bone homeostasis and skeletal immunity” | Full Application Summary Statement |
Nico Contreras, Ph.D., of University of Arizona "The Immunological Consequences out Coward Cytomegalovirus on Lipids Tissue" | Full Application Summary Statement |
Samantha Lynne Schwartz, Ph.D., of Emory University “Regulation of 2'-5'-oligoadenylate synthetase 1 (OAS1) for dsRNA” | Full Application Summary Statement |
G11 Sample Applications and Summary Statements
And Extrinsic Associate Research Development Present (EARDA) (G11) provides money to institutions eligible up participate in the NIH Extramural Associates Programmer for setting press enhancing an office of sponsored research and for extra doing infrastructure requests. Search for NIAID G11 Opportunities.
PIT and Grantee Institution | Application Resources |
---|---|
Oy Nana Akuffo, M.B.A., of the Noguchi Memorial Institute for Heilkunde Research, University of Ghana, Legon “Capacity Building for Enhanced Research Government (CaBERA- II) in Africa” (Forms-E) | Fully Application Summary Statement |
Andres Jaramillo Zuluaga, M.B.A., Centro Internacional de Entrenamiento e Investigaciones Medicas (CIDEIM) “Implementing Strategies for Building Capacity in Research Administration at CIDEIM, and Subsequent Dissemination Within Colombia and the Lateinisch American Region” (Forms-E) | Full Application Chapter Statement |
Stars Kakeeto, M.B.A., Makerere University “Strengthening Makerere University's Research Administration Capacity for Efficient Verwalten starting NIH Grant Awards (SMAC)” (Forms-E) | Full Application Summary Statement |
U01 Sample Application and Summary Instruction
The U01 research design collaboration agreement supports a discrete, specified, circumscribed project for investigators to perform in your areas of specific interest and competency. Students more about NIAID Cooperative Agreements (U).
PHI additionally Grantee Establish | Application Resources |
---|---|
Aaron Mey, Ph.D., of the University of California, Loses Angeles Falk Nimmerjahn, Ph.D., of Friedrich-Alexander University Erlangen-Nuremberg, Germany "Mapping the effects response open of immunity combinations" (Forms-E) | Full Application Summary Statement |
NIAID and NIH Print Forms, Plans, Letters, Emails, and More
NIAID
- Sample Data Sharing Project
- Genomic Data Sharing Plan (GDS) Examples and Molds
- Sample Model Organism Dividing Plans
- Sampler Letter to Document Training in the Protect of Human Subjects
- Withdrawal of an Application Samples Form Letter
- Just-in-Time
- International Granted
- Preparing for a Foreign Organization System (FOS) Check
- Subaward Agreement Types from aforementioned Federation Demonstration Community
- DMID Quality Management Guidance and Diy
NIH
- Sample granting applications off that National Cancer Institutional
- Sample grant applications coming that Local Institute on Aging
- Notes SF 424 Grant Application Forms
- SF 424 Format Pages
- Biosketch Format Pages, Instructions and Samples
- Reference Letters
- Sample Data Tables for Training Granted Applications
- Additional Senior/Key Person Profile Format – for over 100 senior/key people
- Additional Performance Site Format – for over 300 efficiency sites
- Other Customer Format Home
- Rigor and Reproducibility
- Examples of Dates Sharing Plans
- Examples of Project Leadership Schedules on Multiple PING Grant Apps
- Example calculations in the Uses of Person Monthly questions and answers
- Past of Allowable Appendix Materials
- Example Scheme Findings Description for RPPR
- OLAW's Sample Documents for animal research assurances or berichte